Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Sun

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
ACS Omega|August 29, 2019
Alignment of Lyotropic Liquid Crystalline Conjugated Polymers in Floating FilmsDa Seul Yang, Maciej Barłóg, Jongsik Park, et al.
JCI Insight|May 18, 2021
Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosisXinbo Zhang, Jonathan Sun, Alberto Canfrán-Duque, et al.
Nature Communications|February 10, 2024
Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damageInmaculada Ruz-Maldonado, John T Gonzalez, Hanming Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2021
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant RecipientsM Hong Nguyen, Ryan K Shields, Liang Chen, et al.
Nature Metabolism|April 25, 2024
Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiringJonathan Sun, Enric Esplugues, Alicia Bort, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progressionPablo Fernández-Tussy, Jonathan Sun, Magdalena P Cardelo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosisNathan L Price, Xinbo Zhang, Pablo Fernández-Tussy, et al.
The Journal of Clinical Investigation|July 13, 2021
Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in miceAbhishek K Singh, Balkrishna Chaube, Xinbo Zhang, et al.
Circulation Research|May 10, 2022
Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis RegressionXinbo Zhang, Noemi Rotllan, Alberto Canfrán-Duque, et al.
The Journal of Clinical Investigation|November 12, 2019
Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune responseMahnaz Sahraei, Balkrishna Chaube, Yuting Liu, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
ACS Omega|August 29, 2019
Alignment of Lyotropic Liquid Crystalline Conjugated Polymers in Floating FilmsDa Seul Yang, Maciej Barłóg, Jongsik Park, et al.
JCI Insight|May 18, 2021
Deficiency of histone lysine methyltransferase SETDB2 in hematopoietic cells promotes vascular inflammation and accelerates atherosclerosisXinbo Zhang, Jonathan Sun, Alberto Canfrán-Duque, et al.
Nature Communications|February 10, 2024
Heterogeneity of hepatocyte dynamics restores liver architecture after chemical, physical or viral damageInmaculada Ruz-Maldonado, John T Gonzalez, Hanming Zhang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2021
Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant RecipientsM Hong Nguyen, Ryan K Shields, Liang Chen, et al.
Nature Metabolism|April 25, 2024
Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiringJonathan Sun, Enric Esplugues, Alicia Bort, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Hepatocyte-specific miR-33 deletion attenuates NAFLD-NASH-HCC progressionPablo Fernández-Tussy, Jonathan Sun, Magdalena P Cardelo, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosisNathan L Price, Xinbo Zhang, Pablo Fernández-Tussy, et al.
The Journal of Clinical Investigation|July 13, 2021
Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in miceAbhishek K Singh, Balkrishna Chaube, Xinbo Zhang, et al.
Circulation Research|May 10, 2022
Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis RegressionXinbo Zhang, Noemi Rotllan, Alberto Canfrán-Duque, et al.
The Journal of Clinical Investigation|November 12, 2019
Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune responseMahnaz Sahraei, Balkrishna Chaube, Yuting Liu, et al.
Pageof 3